Wanbury Q2 FY25 revenue at Rs. 161.2 crore, up 11.6%
16 Nov 2024 //
INDPHARMAPOST
Wanbury announces new API product portfolio and launch plans
12 Sep 2024 //
EXPRESS PHARMA
Briefs: Wanbury and Bafna Pharmaceuticals
10 Sep 2024 //
INDIANPHARMAPOST
Wanbury receives CEP certification for Dextromethorphan API from EDQM
09 Sep 2024 //
EXPRESSPHARMA
Wanbury jumps 4% after firm gets zero form 483 observations from USFDA
23 Aug 2024 //
BUSINESS STANDARD
Wanbury bags safety awards for its API manufacturing site in Patalganga
22 Aug 2024 //
ECONOMICTIMES
Wanbury appoints Prakash Venkatraman as President of API business
16 Aug 2024 //
EXPRESSPHARMA
Cipla acquires 4 key brands from Wanbury for up to Rs 89 crore
10 Feb 2020 //
ECONIMIC TIMES
Cipla acquires 4 key brands from Wanbury for up to Rs 89 crore
10 Feb 2020 //
ECONIMIC TIMES
After India, European Union to probe Wanbury Pharma for illegal export
01 Nov 2016 //
ECONOMIC TIMES
Thane FDA sends show-cause notice to Wanbury Pharma
26 Oct 2016 //
ECONOMIC TIMES
Wanbury Export Issue Shows Regulator Miscommunication
25 Oct 2016 //
ECONOMIC TIMES
Bulk drugs from China floods Indian market
11 Dec 2015 //
ECONOMIC TIMES